Sellas Life Sciences Raises $31 Million From Exercise of Warrants
MT Newswires Live
Oct 27
Sellas Life Sciences Group (SLS) said Monday an institutional investor exercised warrants to purchase up to around 22.4 million shares for gross cash proceeds of about $31 million.
The investor will receive new registered warrants to purchase up to around 22.4 million shares at an exercise price of $2.00, which will be exercisable immediately and expire five years from the date of issuance, the company said.
The transaction is expected to close on or about Tuesday, Sellas said.
Shares of the company were down more than 2% in early trading Monday.
Price: 1.94, Change: -0.05, Percent Change: -2.51
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.